The Thailand Office of Insurance Commission outlined a policy direction for Thailand’s private health insurance system in a keynote address at the 21st Thailand Insurance Medical Academic Conference 2026, urging a shift from insurers acting mainly as claims payers to a “Health Partner” model that supports prevention, proactive health management and appropriate use of medical services. The message focused on sustaining the system as Thailand enters a fully ageing society and faces health-cost growth that outpaces general inflation. The Office highlighted that premium growth has been driven by higher costs per person rather than an expanding insured population, creating a risk of a high-premium cycle that pushes healthier policyholders out of the system and undermines overall stability. Policy directions set out include expanding coverage to middle-income groups and people with public-sector benefits so private insurance complements core health provision, promoting greater use of public hospitals alongside value-based healthcare to reduce system-wide costs, developing standardized prescriptions and allowing policyholders to purchase medicines outside hospitals to reduce expenses, and advancing a standard treatment-cost database (SIMBII) with central data linkage to improve transparency and support more appropriate premium-setting. The agenda also referenced systematic management of medical inflation and the use of copayment measures to encourage more appropriate healthcare utilisation.
Thailand Office of Insurance Commission 2026-03-27
Thailand Office of Insurance Commission sets direction to shift private health insurers into Health Partners while expanding coverage and curbing medical inflation
The Thailand Office of Insurance Commission announced a shift to a "Health Partner" model for private health insurance, focusing on prevention and proactive health management. The policy aims to address high health-cost growth and premium cycles by expanding coverage to middle-income groups, promoting public hospital use, and developing a standard treatment-cost database. Additional measures include standardized prescriptions, allowing medicine purchases outside hospitals, and implementing copayment strategies to manage medical inflation.